Meet the CP Team
Experts in Innovative High Throughput Experimentation and Continuous Flow Synthesis
Collaborators With Academia and Industry
Member of the FDA Emerging Technology Program
Subscribe To Our Mailing List
Hero Request Form
A Team of Professionals
Join Our Team
Download the position description below and if interested email nlhathaway@continuitypharma.com
Partners & Associations
- API Innovation Center @ Cortex
- Purdue Institute for Cancer Research
- FDA Emerging Technology Program
- William D. and Sherry L. Young Institute for the Advance Manufacturing of Pharmaceuticals
- Charlotte Wiles, PhD, CEO – ChemTrix
- Eyal Barash, Barash Law
- Steve Byrn, PhD, CEO – Improved Pharma
- Vadim Gurvich, PhD, MBA - University of Minnesota Institute for Therapeutics Discovery & Development
- National Institute for Pharmaceutical Technology & Education (NIPTE)
Leadership
List of Services
-
Nancy Hathaway, JD, Co-Founder and CEOList Item 1
Nancy is an experienced entrepreneur with a demonstrated history of working in the research industry to move innovations from bench to bedside. She is skilled in Rare Diseases, Staff Development, Regulatory Compliance, and Human Subject Protection.
-
David H Thompson, PhD, Co-Founder and CSOList Item 2
David has extensive experience in developing novel continuous manufacturing processes using green chemistry principles. As a Professor of Chemistry at Purdue University, his team has developed continuous manufacturing and high-throughput experimentation methods that have appeared in top journals such as Chemical Science, Chemistry, ACS Combinatorial Science, and Organic Process Research and Development. With Continuity, David and his team have created continuous manufacturing trains for multiple synthetic targets.
Share On: